Posted inHealth

Advocates say ‘perfect storm’ of possible cuts threatens mental health care

Proposed reductions to Medicaid, coupled with state budget cuts under consideration, concern mental health advocates, who say lowering eligibility for Medicaid without providing other options would result in the cycling of patients in and out of care. When people can’t work, advocates say, they go on public assistance programs, costing the state more than they would have if they had been allowed to stay on Medicaid and remain in treatment.

Posted inHealth, Politics

Pence, Malloy compete to define what GOP is doing to health care

PROVIDENCE, R.I. — Vice President Mike Pence told the National Governors Association that the Trump administration is intent on saving Medicaid, albeit by shrinking its reach or sharing more costs with the states. The Democratic governors said the Trump strategy for making Medicaid financially sustainable would either bankrupt states or deny coverage to vulnerable Americans.

Posted inHealth, Politics

McConnell tweaks health care bill to win conservative support

WASHINGTON — Sen. Mitch McConnell rolled out a new health care bill that is broadly similar to the one that foundered in the Senate last month, but contains a few new provisions aimed at winning over recalcitrant Republican senators. The new bill was excoriated by Connecticut Democrats, and increased Democratic opposition to the effort to repeal and replace the Affordable Care Act.

Posted inHealth, Politics

Malloy signs pharmacy bill — and a withering P.S.

Gov. Dannel P. Malloy signed a consumer-protection bill into law Monday, but not before penning an unusual letter reviving his criticism of how the law’s influential sponsors, the top Democratic and Republican leaders of the Senate, rebuffed his insurance commissioner’s efforts to shape a bipartisan measure intended to cut the cost of prescription drugs.

Posted inHealth, Justice

Growing number of states press opioid suits against Stamford’s Purdue Pharma

Updated at 10:15 a.m. with industry comment 
WASHINGTON — Stamford-based Purdue Pharma, the maker of pain-killer OxyContin, is the target of an increasing number of suits by states, counties and cities alleging it is partly to blame for the nation’s opioid epidemic. The lawsuits are all different and some include other pharmaceutical companies and pharmacies as defendants. But Purdue is nearly always a main defendant. 

Posted inHealth, Politics

Safe under ACA, patients with preexisting conditions now afraid

With the protections of Obamacare in place, physicians in recent years have urged patients to be screened for a variety of diseases and predispositions to illness, feeling confident it would not affect their future insurability. Now genetics experts and patient advocates worry that people are already shying away from testing as the health law’s future becomes more uncertain.

Gift this article